#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neutropenia Central nervous system lymphoma Aplastic anaemia Renal cell carcinoma Neurofibromatosis Intracranial calcification Congenital cystic kidney disease Rosai-Dorfman syndrome Hypergammaglobulinaemia benign monoclonal Neuroendocrine carcinoma Wiskott-Aldrich syndrome Pulmonary tuberculosis Antisynthetase syndrome Extra-osseous Ewing's sarcoma Neurotrophic keratopathy More trials…

    Learn about Rare Diseases

    Indolent systemic mastocytosis – Basic Information Osteosarcoma – Diagnostics Mitochondrial myopathy – Trials in Disease Mast cell activation syndrome – Basic Information Von Willebrand’s disease – Trials in Disease Piriformis syndrome – Diagnostics Leiomyosarcoma Prader-Willi syndrome – Treatment Hepatic angiosarcoma – Diagnostics Mantle cell lymphoma stage II – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Hst-1011 Quinapril Hydrochloride Leuprorelin ATTR-01 Indometacin Oxygen Almagate Anastrozole Soya Oil, Purified Dazodalibep Biotin ADX-324 Dabigatran Etexilate Ursodoxicoltaurine Cat Epithelium Extract Cagrilintide Ima402 KETOROLAC ABBV-CLS-628 Isoniazid More therapies…

    Learn about Your Condition

    Angiopathy Endometrial adenocarcinoma Periodontitis Cytomegalovirus infection Hereditary angioedema Streptococcal infection Psychological trauma Systemic sclerosis pulmonary Astrocytoma malignant Gouty arthritis Cardiovascular disorder Colitis ulcerative T-cell lymphoma Breast cancer recurrent Spina bifida More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Kardiologische Praxis Dr. med. Ayham Al-Zoebi Wermsdorf…

Kardiologische Praxis Dr. med. Ayham Al-Zoebi Wermsdorf

Clara-Zetkin-Strasse 23, Wermsdorf, 04779, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Baxdrostat for Reducing Blood Pressure in Patients with Uncontrolled or Resistant Hypertension

    Not recruiting

    3 1
    Investigated Diseases:
    • Hypertension
    Investigated Drugs:
    • Baxdrostat
    Austria Belgium Bulgaria Czechia Denmark France +8

  • Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Andexanet Alfa
    • Apixaban
    • Milvexian
    Belgium Bulgaria Croatia Czechia Denmark Estonia +13

  • Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Atrial fibrillation
    • Thrombosis prophylaxis
    Investigated Drugs:
    • Apixaban
    • Asundexian
    Austria Belgium Bulgaria Czechia Denmark Estonia +16
Previous Page
1 2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!